Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • NEKTAR THERAPEUTICS Financial Overview

  • Income Statement: NKTR

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 90.18 M 273.03 M -182.84 M -202.74%
    Gross Profit 56.52 M 125.54 M -69.02 M -122.12%
    Net Income Before Extra Items/Preferred Div -34.34 M -32.76 M -1.58 M 4.59%
    Operating Income -145.79 M -76.96 M -68.83 M 47.21%
  • Cash Flow: NKTR

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing -49.74 M -101.77 M 52.03 M -104.60%
    Net Cash Flow - Investing -274.65 M 32.66 M -307.31 M 111.89%
    Net Cash Flow/Operating Activities -145.78 M 146.30 M -292.08 M 200.36%
  • Balance Sheet: NKTR

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 560.54 M 725.10 M -164.57 M -29.36%
    Total Liabilities 370.38 M 510.66 M -140.28 M -37.87%
    Shareholders Equity 190.15 M 214.44 M -24.28 M -12.77%
  • Key Ratios / Statistics: NKTR

    • Valuation

      Price/Earnings (TTM) -15.03
      Price/Sales (TTM) 5.70
      Price/Book (MRQ) 8.55
      Price/Cash Flow (TTM) -7.42
    • Profitability

      Gross Margin 62.67
      Operating Margin -161.66
      Profit Margin -38.07
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 5.71
      Current Ratio (MRQ) 6.04
      Long Term Debt-to-Equity (MRQ) 220.72
    • Management Effectiveness

      Return on Equity (TTM) -16.90
      Return on Assets (TTM) -1.94
      Return on Investments (TTM) -5.00